AzTrials
AzTrials

Parkinson's DiseaseNCT06154356

Action Observation and Motor Imagery Therapy in Parkinson's Disease

A study testing Action observation and motor imagery therapy for rehabilitation in people with Parkinson's Disease, run by Karamanoğlu Mehmetbey University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

In recent years, motor imagery (MI) and action observation (AO) therapy strategies have been used in rehabilitation programs to increase motor learning in Parkinson's disease (PD). Visuomotor training strategies such as AO and MI therapy rely on the activity of the mirror neuron system to facilitate motor re-learning. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Parkinson's Disease
What is being tested?
Action observation and motor imagery therapy for rehabilitation
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
54 participants
Where
1 siteTurkey (Türkiye)
Study dates
14 Dec 2023to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with a diagnosis of Parkinson's Disease
  • Hoehn and Yahr Stage 1-3

Who cannot join

  • Patients with cognitive dysfunction (those who cannot follow simple verbal instructions)
  • Patients with severe hearing problems
  • Patients with severe vision problems
  • Patients with additional musculoskeletal system pathology that will affect physical performance (such as amputation, severe joint mobility limitation, peripheral nerve damage)
  • Patients with uncontrolled hypertension and diabetes mellitus
  • Patients with a history of symptomatic lung disease (such as asthma, chronic obstructive pulmonary disease, emphysema)
  • Patients with a history of symptomatic cardiac disease (such as coronary artery disease, arrhythmia, heart failure)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Yurdagul Bahran Mustu, MD. contact

+90 506 209 76 72

yurdagulbahran@gmail.com

Aynur Basaran, MD, Prof. contact

aynurbasaran@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Karaman Training and Research Hospital

    Karaman, Karaman, 70200

    Yurdagul Bahran Mustu, MD., +90 338 226 3228, yurdagulbahran@gmail.com

    Aynur Basaran, MD, Prof., +90 338 226 3225, aynurbasaran@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Effect of Action Observation and Motor Imagery Therapy on Balance, Functional Status and Quality of Life in Parkinson's Disease, Randomized Controlled Trial

In recent years, motor imagery (MI) and action observation (AO) therapy strategies have been used in rehabilitation programs to increase motor learning in Parkinson's disease (PD). Visuomotor training strategies such as AO and MI therapy rely on the activity of the mirror neuron system to facilitate motor re-learning. Mirror neurons are activated during the performance of goal-directed actions, also when observing the same action and visualizing the action in the mind.

The aim of this clinical trial is to test whether the application of AO and MI treatment in PD in addition to conventional rehabilitation programs has an additional effect on Balance, Functional Status and Quality of Life.

Read the detailed description

Parkinson's disease (PD) is a neurodegenerative disease with a chronic and progressive course. Freezing phenomena, gait disorders, and balance problems are common in PD. Gait and balance disorders and motor freezing attacks that occur as a result of PD increase the risk of falling, leading to a decrease in functional independence and quality of life. The main goal of Parkinson's rehabilitation is to ensure the maximum functional status and independence in daily living activities and to increase their quality of life.

In recent years, motor imagery (MI) and action observation (AO) therapy strategies have been used in rehabilitation programs to increase motor learning in PD. Visuomotor training strategies such as AO and MI therapy rely on the activity of the mirror neuron system to facilitate motor re-learning. Mirror neurons are activated during the performance of goal-directed actions, also when observing the same action and visualizing the action in the mind.

The aim of this clinical trial is to test whether the application of AO and MI treatment in PD in addition to conventional rehabilitation programs has an additional effect on Balance, Functional Status and Quality of Life.

Being tested
Action observation and motor imagery therapy for rehabilitation, Sham action observation and motor imagery therapy for rehabilitation
Medical subject headings
Parkinson Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Action observation and motor imagery therapy for rehabilitationOther

    Action observation; Patients will watch some exercises accompanied by music from a previously prepared video for 10 minutes. Exercises include 8-10 repetitions of abduction-adduction, horizontal abduction-adduction, flexion-extension and supination-pronation movements for the upper extremity, and stepping, forward-backward stepping, side stepping and ankle dorsiflexion movements for the lower extremity.

    Motor imagery training; Patients will be asked to visualize the actions they watched in their minds for 10 minutes.

    Then the patients will watch the video again and will be asked to perform the exercises while watching.

  • Sham action observation and motor imagery therapy for rehabilitationOther

    Sham action observation; Patients will watch a video consisting of static nature photographs for 10 minutes with the same music.

    Sham motor imaginary; Patients will think about the video they watched for 10 minutes.

    Then, they will watch another video in which the exercises are performed only once, and they will be asked to do the exercises. They will be given enough time to do 8-10 repetitions.

Study groups in NCT06154356
Study groupRoleWhat they receive
Action observation and motor imagery therapy for rehabilitationExperimentalAction observation and motor imagery therapy for rehabilitation in Parkinson's Disease in addition to conventional rehabilitation programs.
Receives: Other: Action observation and motor imagery therapy for rehabilitation
Sham action observation and motor imagery therapy for rehabilitationSham comparatorSham comparator for action observation and motor imagery therapy for rehabilitation in Parkinson's Disease in addition to conventional rehabilitation programs.
Receives: Other: Sham action observation and motor imagery therapy for rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The difference in the scores of the Berg Balance Scale between pre- and post-rehabilitation assessments

    Univariate statistical analyses will be performed to calculate differences in the scores of the Berg Balance Scale between pre- and post-rehabilitation assessments.

    Berg Balance Scale consists of 14 items. Total score ranges from 0 to 56. Higher scores indicate better balance.

    Measured: 6 weeks

  2. The difference in the scores of the The Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale pre- and post-rehabilitation assessments

    Univariate statistical analyses will be performed to calculate differences in the scores of the The Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale between pre- and post-rehabilitation assessments.

    The Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) consists of four sections: Part 1: non-motor experiences of daily living, Part 2: motor experiences of daily living, Part 3: motor examination, Part 4: motor complications. It consists of a total of 50 questions. In this study, sections II (motor experiences of daily living) and III (motor examination) will be used. Each item is is scored between 0 and 4. Higher values indicate that the patient's condition is worse.

    Measured: 6 weeks

  3. The difference in the scores of the Timed Up and Go Test between pre- and post-rehabilitation assessments

    Univariate statistical analyses will be performed to calculate differences in the scores of the Timed Up and Go Test between pre- and post-rehabilitation assessments

    Measured: 6 weeks

  4. The difference in the scores of the Five Times Sit to Stand Test between pre- and post-rehabilitation assessments

    Univariate statistical analyses will be performed to calculate differences in the scores of the Five Times Sit to Stand Test between pre- and post-rehabilitation assessments

    Measured: 6 weeks

Secondary outcomes (2)
  1. The difference in the scores of the Parkinson's Disease Questionnaire between pre- and post-rehabilitation assessments

    Univariate statistical analyses will be performed to calculate differences in the scores of the Parkinson's Disease Questionnaire (PDQ-39) between pre- and post-rehabilitation assessments.

    Parkinson's Disease Questionnaire consists of a total of 39 items and eight subgroups. In the survey, each item is scored between 0 and 4. Lower scores indicate better quality of life.

    Measured: 6 weeks

  2. The difference in the scores of the Freezing of Gait Questionnaire between pre- and post-rehabilitation assessments

    Univariate statistical analyses will be performed to calculate differences in the scores of the Freezing of Gait Questionnaire between pre- and post-rehabilitation assessments.

    Freezing of Gait Questionnaire consists of six questions. Each question has a 5-point scale, where 0 means an absence of symptoms and 4 represents the worst stage. The total score on the Freezing of Gait Questionnaire ranges from 0 to 24 points. The higher the score is, the more the Freezing of Gait is pronounced.

    Measured: 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Dec 2023
  2. Study start14 Dec 2023
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Prospective randomized controlled study
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
54 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06154356
Sponsor's protocol ID
09-2023/03
Status last verified
Aug 2026
First submitted
23 Nov 2023
Last updated
5 Aug 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Action observation and motor imagery therapy for rehabilitation in people with Parkinson's Disease, run by Karamanoğlu Mehmetbey University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yurdagul Bahran Mustu, MD. (+90 506 209 76 72, yurdagulbahran@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The difference in the scores of the Berg Balance Scale between pre- and post-rehabilitation assessments (time frame: 6 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in